OUTCOMES IN FIRST RELAPSED-REFRACTORY YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: RESULTS FROM THE MANTLE-FIRST STUDY

被引：0
|
作者：
Visco, C.
Di Rocco, A.
Tisi, M.
Morello, L.
Evangelista, A.
Zilioli, V. R.
Rusconi, C.
Hohaus, S.
Sciarra, R.
Re, A.
Tecchio, C.
Chiappella, A.
Niebla, A. M.
McCulloch, R.
Gini, G.
Perrone, T.
Nassi, L.
Pennese, E.
Stefani, P. M.
Cox, M. C.
Bozzoli, V.
Fabbri, A.
Polli, V.
Ferrero, S.
De Celis, I. A.
Sica, A.
Arcaini, L.
Balzarotti, M.
Rule, S.
Vitolo, U.
机构：
[1] Univ Verona, Sect Hematol, Dept Med, Verona, Italy
[2] Sapienza Univ, Cellular Biotechnol & Hematol, Rome, Italy
[3] San Bortolo Hosp, Cell Therapy & Hematol, Vicenza, Italy
[4] Humanitas Clin & Res Ctr, Hematol, Milan, Italy
[5] Citta Salute & Sci, Clin Epidemiol, Turin, Italy
[6] CPO Piemonte, Turin, Italy
[7] ASST Grande Osped Metropolitano Niguarda, Hematol, Milan, Italy
[8] Univ Cattolica Sacro Cuore, Policlin Gemelli Fdn, Inst Hematol, Rome, Italy
[9] Fdn IRCCS Policlin San Matteo, Haematol Oncol, Pavia, Italy
[10] Spedali Civil Brescia, Hematol, Brescia, Italy
[11] Citta Salute & Sci Univ Hosp, Hematol, Turin, Italy
[12] Vall dHebron Inst Recerca, Hematol, Barcelona, Spain
[13] Univ Plymouth, Haematol, Plymouth, Devon, England
[14] Derriford Hosp, Plymouth, Devon, England
[15] Marche Polytech Univ, Dept Clin & Mol Sci, Hematol, Ancona, Italy
[16] Univ Bari, Hematol, Bari, Italy
[17] Azienda Osped Univ Maggiore Carita, Hematol, Novara, Italy
[18] PO Santo Spirito, UOSD Ctr Diag & Terapia Linfomi, Hematol, Florence, Italy
[19] Treviso Hosp, Hematol, Treviso, Italy
[20] AOU St Andrea, Hematol, Rome, Italy
[21] PO V Fazzi, Hematol, Lecce, Italy
[22] Azienda Osped Univ Senese, Hematol, Siena, Italy
[23] Univ Siena, Siena, Italy
[24] Osped Infermi, Hematol, Rimini, Italy
[25] Univ Torino, Mol Biotechnol & Hlth Sci, AOU Citta Salute & Sci Torino, Turin, Italy
[26] AUSLL IRCCS Santa Maria Nuova Hosp, Hematol, Reggio Emilia, Italy
[27] Policlin Napoli, Hematol, Naples, Italy
来源：
HAEMATOLOGICA | 2019年 / 104卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
C001
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [41] Evolving treatment patterns and improved outcomes in relapsed/refractory mantle cell lymphoma: a prospective cohort study
    Bock, Allison M.
    Gile, Jennifer J.
    Larson, Melissa C.
    Poonsombudlert, Kittika
    Tawfiq, Reema K.
    Maliske, Seth
    Maurer, Matthew J.
    Kabat, Brian F.
    Paludo, Jonas
    Inwards, David J.
    Ayyappan, Sabarish
    Link, Brian K.
    Ansell, Stephen M.
    Habermann, Thomas M.
    Witzig, Thomas E.
    Nowakowski, Grzegorz S.
    Cerhan, James R.
    Farooq, Umar
    Wang, Yucai
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [42] Ibrutinib-Lenalidomide-Rituximab in Patients with Relapsed/Refractory Mantle Cell Lymphoma: First Results from the Nordic Lymphoma Group MCL6 (PHILEMON) Phase II Trial
    Jerkeman, Mats
    Hutchings, Martin
    Raty, Riikka
    Wader, Karin Fahl
    Laurell, Anna
    Kuitunen, Hanne
    Toldbod, Helle
    Pedersen, Lone Bredo
    Eskelund, Christian Winther
    Gronbaek, Kirsten
    Niemann, Carsten Utoft
    Geisler, Christian H.
    Kolstad, Arne
    BLOOD, 2016, 128 (22)
  • [43] Lenalidomide in relapsed or refractory mantle cell lymphoma: overview and perspective
    Desai, Madhav
    Newberry, Kate
    Ou, Zhishuo
    Wang, Michael
    Zhang, Liang
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2014, 5 (03) : 91 - 101
  • [44] Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma
    Satoshi Yamasaki
    Dai Chihara
    Sung-Won Kim
    Koji Izutsu
    Kouji Iwato
    Takahiro Fukuda
    Naoyuki Uchida
    Itsuto Amano
    Hideyuki Nakazawa
    Junya Kuroda
    Hisako Hashimoto
    Tatsuo Ichinohe
    Yoshinobu Kanda
    Yoshiko Atsuta
    Junji Suzumiya
    Ritsuro Suzuki
    Annals of Hematology, 2018, 97 : 1445 - 1452
  • [45] Novel Treatment Approaches in Relapsed/Refractory Mantle Cell Lymphoma
    Maddocks, Kami
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S187 - S188
  • [46] Mantle Cell Lymphoma: Updates in the Management of Relapsed/Refractory Disease
    Shadman, Mazyar
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (11.5): : 1331 - 1333
  • [47] Ibrutinib in refractory mantle cell lymphoma or relapsed data update
    Paillassa, Jerome
    HEMATOLOGIE, 2015, 21 (05): : 257 - 259
  • [48] Temsirolimus in Relapsed and/or Refractory Mantle Cell Lymphoma Profile Report
    Hoy, Sheridan M.
    McKeage, Kate
    BIODRUGS, 2011, 25 (03) : 193 - 195
  • [49] Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma
    Mian, Agrima
    Hill, Brian T.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (04) : 435 - 441
  • [50] A Systematic Review of Treatments of Relapsed/Refractory Mantle Cell Lymphoma
    Parrott, Madeliene
    Rule, Simon
    Kelleher, Michael
    Wilson, Jayne
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2018, 18 (01): : 13 - +
12345